The PATH-OCD research team is a multidisciplinary group of clinicians and researchers committed to advancing the understanding and treatment of severe, treatment-resistant obsessive-compulsive disorder (OCD).
PATH-OCD is an observational study conducted at Lund University and Region Skåne, following patients who receive repetitive transcranial magnetic stimulation (rTMS) as part of routine clinical care. By collecting real-world clinical data, the team aims to evaluate treatment outcomes, identify factors associated with response, and contribute to the development of more effective, evidence-based treatment strategies for individuals living with treatment-resistant OCD.
Pouya Movahed Rad, MD, PhD
Principal Investigator
Consultant Psychiatrist and Associate Professor at Lund University Dr. Movahed Rad brings deep clinical and research experience in psychiatry, with a special focus on severe depression. He has led clinical trials involving treatments such as electroconvulsive therapy (ECT), ketamine, and now psychedelic-assisted interventions.
Carl Lindoff Gustafsson
Research Fellow
